Special Organic Chemistry Seminar
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
Process Development of a VEGF Inhibitor for the Treatment of Cancer
Michael J. Rozema,
Dr.,
GPRD Process Research & Development,
Abbott Laboratories,
"Process Development of a VEGF Inhibitor for the Treatment of Cancer," Michael J. Rozema, GPRD Process Research & Development, Abbott Laboratories.
For more information, please contact Arleen (Lynne) Martinez by phone at 4004 or by email at [email protected].
Event Series
Special Organic Chemistry Seminar Series